nodes	percent_of_prediction	percent_of_DWPC	metapath
Olopatadine—CYP3A4—Temozolomide—brain cancer	0.104	0.487	CbGbCtD
Olopatadine—CYP3A4—Lomustine—brain cancer	0.0883	0.414	CbGbCtD
Olopatadine—S100A12—nose—brain cancer	0.0773	0.204	CbGeAlD
Olopatadine—S100A1—ganglion—brain cancer	0.025	0.0661	CbGeAlD
Olopatadine—S100B—ganglion—brain cancer	0.0216	0.0571	CbGeAlD
Olopatadine—CYP3A4—Etoposide—brain cancer	0.0213	0.1	CbGbCtD
Olopatadine—S100A2—Direct p53 effectors—HIC1—brain cancer	0.0184	0.093	CbGpPWpGaD
Olopatadine—S100B—blood vessel—brain cancer	0.0172	0.0454	CbGeAlD
Olopatadine—S100B—hindbrain—brain cancer	0.0164	0.0433	CbGeAlD
Olopatadine—HRH1—nose—brain cancer	0.0156	0.0414	CbGeAlD
Olopatadine—S100A2—Validated transcriptional targets of TAp63 isoforms—SHH—brain cancer	0.0131	0.0661	CbGpPWpGaD
Olopatadine—S100A2—Direct p53 effectors—PMS2—brain cancer	0.00967	0.0488	CbGpPWpGaD
Olopatadine—S100A1—telencephalon—brain cancer	0.00964	0.0255	CbGeAlD
Olopatadine—S100B—brainstem—brain cancer	0.00938	0.0248	CbGeAlD
Olopatadine—Hyperaemia—Carmustine—brain cancer	0.00855	0.0412	CcSEcCtD
Olopatadine—S100A2—pituitary gland—brain cancer	0.00852	0.0225	CbGeAlD
Olopatadine—S100B—telencephalon—brain cancer	0.00832	0.022	CbGeAlD
Olopatadine—S100A2—p73 transcription factor network—CDK6—brain cancer	0.00816	0.0412	CbGpPWpGaD
Olopatadine—S100A1—pituitary gland—brain cancer	0.00785	0.0208	CbGeAlD
Olopatadine—S100A1—medulla oblongata—brain cancer	0.00757	0.02	CbGeAlD
Olopatadine—S100B—Nuclear signaling by ERBB4—GFAP—brain cancer	0.00721	0.0364	CbGpPWpGaD
Olopatadine—Oropharyngeal pain—Lomustine—brain cancer	0.00715	0.0344	CcSEcCtD
Olopatadine—S100A13—gonad—brain cancer	0.00713	0.0189	CbGeAlD
Olopatadine—S100A1—midbrain—brain cancer	0.00692	0.0183	CbGeAlD
Olopatadine—S100A12—pituitary gland—brain cancer	0.00687	0.0182	CbGeAlD
Olopatadine—S100A1—spinal cord—brain cancer	0.00675	0.0179	CbGeAlD
Olopatadine—S100A2—endocrine gland—brain cancer	0.0066	0.0175	CbGeAlD
Olopatadine—S100A2—head—brain cancer	0.00651	0.0172	CbGeAlD
Olopatadine—S100A2—p73 transcription factor network—BRCA2—brain cancer	0.00634	0.032	CbGpPWpGaD
Olopatadine—S100A2—p73 transcription factor network—SIRT1—brain cancer	0.00622	0.0314	CbGpPWpGaD
Olopatadine—S100A1—endocrine gland—brain cancer	0.00608	0.0161	CbGeAlD
Olopatadine—S100A1—head—brain cancer	0.006	0.0159	CbGeAlD
Olopatadine—S100B—midbrain—brain cancer	0.00598	0.0158	CbGeAlD
Olopatadine—S100B—spinal cord—brain cancer	0.00583	0.0154	CbGeAlD
Olopatadine—S100A1—central nervous system—brain cancer	0.00548	0.0145	CbGeAlD
Olopatadine—S100A13—endocrine gland—brain cancer	0.00539	0.0143	CbGeAlD
Olopatadine—S100A1—cerebellum—brain cancer	0.00535	0.0142	CbGeAlD
Olopatadine—S100A13—head—brain cancer	0.00532	0.0141	CbGeAlD
Olopatadine—S100A12—endocrine gland—brain cancer	0.00532	0.0141	CbGeAlD
Olopatadine—S100A12—head—brain cancer	0.00525	0.0139	CbGeAlD
Olopatadine—S100B—endocrine gland—brain cancer	0.00525	0.0139	CbGeAlD
Olopatadine—S100A12—DEx/H-box helicases activate type I IFN and inflammatory cytokines production—RELA—brain cancer	0.0052	0.0263	CbGpPWpGaD
Olopatadine—S100B—head—brain cancer	0.00518	0.0137	CbGeAlD
Olopatadine—Visual disturbance—Lomustine—brain cancer	0.00498	0.024	CcSEcCtD
Olopatadine—S100B—DEx/H-box helicases activate type I IFN and inflammatory cytokines production—RELA—brain cancer	0.00492	0.0248	CbGpPWpGaD
Olopatadine—S100A2—Validated transcriptional targets of TAp63 isoforms—CDKN2A—brain cancer	0.00487	0.0246	CbGpPWpGaD
Olopatadine—S100A13—central nervous system—brain cancer	0.00486	0.0129	CbGeAlD
Olopatadine—S100A13—cerebellum—brain cancer	0.00475	0.0126	CbGeAlD
Olopatadine—S100B—central nervous system—brain cancer	0.00473	0.0125	CbGeAlD
Olopatadine—S100A2—brain—brain cancer	0.00472	0.0125	CbGeAlD
Olopatadine—S100B—cerebellum—brain cancer	0.00462	0.0122	CbGeAlD
Olopatadine—S100A1—brain—brain cancer	0.00435	0.0115	CbGeAlD
Olopatadine—Visual acuity reduced—Temozolomide—brain cancer	0.00419	0.0202	CcSEcCtD
Olopatadine—Photophobia—Procarbazine—brain cancer	0.00387	0.0186	CcSEcCtD
Olopatadine—S100A13—brain—brain cancer	0.00386	0.0102	CbGeAlD
Olopatadine—S100A12—brain—brain cancer	0.00381	0.0101	CbGeAlD
Olopatadine—S100B—brain—brain cancer	0.00376	0.00993	CbGeAlD
Olopatadine—S100A12—RIP-mediated NFkB activation via ZBP1—RELA—brain cancer	0.00354	0.0179	CbGpPWpGaD
Olopatadine—S100A2—Direct p53 effectors—SPP1—brain cancer	0.00351	0.0177	CbGpPWpGaD
Olopatadine—S100A2—p73 transcription factor network—RELA—brain cancer	0.00346	0.0175	CbGpPWpGaD
Olopatadine—S100A2—Direct p53 effectors—PCNA—brain cancer	0.00344	0.0174	CbGpPWpGaD
Olopatadine—Ulcer—Hydroxyurea—brain cancer	0.00338	0.0163	CcSEcCtD
Olopatadine—S100B—RIP-mediated NFkB activation via ZBP1—RELA—brain cancer	0.00335	0.0169	CbGpPWpGaD
Olopatadine—S100A12—TRAF6 mediated NF-kB activation—RELA—brain cancer	0.00318	0.0161	CbGpPWpGaD
Olopatadine—Visual impairment—Lomustine—brain cancer	0.00315	0.0151	CcSEcCtD
Olopatadine—S100B—TRAF6 mediated NF-kB activation—RELA—brain cancer	0.00301	0.0152	CbGpPWpGaD
Olopatadine—S100A12—ZBP1(DAI) mediated induction of type I IFNs—RELA—brain cancer	0.00299	0.0151	CbGpPWpGaD
Olopatadine—S100A12—TAK1 activates NFkB by phosphorylation and activation of IKKs complex—RELA—brain cancer	0.00299	0.0151	CbGpPWpGaD
Olopatadine—S100B—TAK1 activates NFkB by phosphorylation and activation of IKKs complex—RELA—brain cancer	0.00282	0.0143	CbGpPWpGaD
Olopatadine—S100B—ZBP1(DAI) mediated induction of type I IFNs—RELA—brain cancer	0.00282	0.0143	CbGpPWpGaD
Olopatadine—S100A2—Direct p53 effectors—APC—brain cancer	0.0028	0.0142	CbGpPWpGaD
Olopatadine—Infection—Carboplatin—brain cancer	0.00263	0.0127	CcSEcCtD
Olopatadine—S100A2—p73 transcription factor network—MYC—brain cancer	0.00244	0.0123	CbGpPWpGaD
Olopatadine—S100B—Signaling by ERBB4—GFAP—brain cancer	0.00243	0.0123	CbGpPWpGaD
Olopatadine—Dry eye—Temozolomide—brain cancer	0.0023	0.0111	CcSEcCtD
Olopatadine—Infection—Lomustine—brain cancer	0.0023	0.0111	CcSEcCtD
Olopatadine—Pain—Carboplatin—brain cancer	0.00227	0.0109	CcSEcCtD
Olopatadine—Epistaxis—Procarbazine—brain cancer	0.00218	0.0105	CcSEcCtD
Olopatadine—Ulcer—Etoposide—brain cancer	0.00211	0.0102	CcSEcCtD
Olopatadine—Body temperature increased—Carboplatin—brain cancer	0.0021	0.0101	CcSEcCtD
Olopatadine—Eye pain—Carmustine—brain cancer	0.00208	0.00999	CcSEcCtD
Olopatadine—Eye pain—Temozolomide—brain cancer	0.00201	0.00966	CcSEcCtD
Olopatadine—Thirst—Temozolomide—brain cancer	0.0019	0.00916	CcSEcCtD
Olopatadine—Body temperature increased—Lomustine—brain cancer	0.00183	0.00882	CcSEcCtD
Olopatadine—CYP3A4—Xenobiotics—CYP2C9—brain cancer	0.00182	0.00922	CbGpPWpGaD
Olopatadine—Weight increased—Hydroxyurea—brain cancer	0.00182	0.00878	CcSEcCtD
Olopatadine—Infestation NOS—Hydroxyurea—brain cancer	0.00179	0.0086	CcSEcCtD
Olopatadine—Infestation—Hydroxyurea—brain cancer	0.00179	0.0086	CcSEcCtD
Olopatadine—CYP3A4—Tamoxifen metabolism—CYP2C9—brain cancer	0.00175	0.00887	CbGpPWpGaD
Olopatadine—HRH1—telencephalon—brain cancer	0.00171	0.00452	CbGeAlD
Olopatadine—Dry skin—Temozolomide—brain cancer	0.00166	0.00799	CcSEcCtD
Olopatadine—Cough—Procarbazine—brain cancer	0.00157	0.00758	CcSEcCtD
Olopatadine—S100A2—Direct p53 effectors—EGFR—brain cancer	0.00151	0.00762	CbGpPWpGaD
Olopatadine—Dry mouth—Procarbazine—brain cancer	0.0015	0.00723	CcSEcCtD
Olopatadine—Vomiting—Lomustine—brain cancer	0.00147	0.0071	CcSEcCtD
Olopatadine—Oedema—Procarbazine—brain cancer	0.00147	0.00709	CcSEcCtD
Olopatadine—Infection—Procarbazine—brain cancer	0.00146	0.00704	CcSEcCtD
Olopatadine—Upper respiratory tract infection—Temozolomide—brain cancer	0.00145	0.007	CcSEcCtD
Olopatadine—Depression—Carmustine—brain cancer	0.00144	0.00693	CcSEcCtD
Olopatadine—Weight increased—Temozolomide—brain cancer	0.00142	0.00686	CcSEcCtD
Olopatadine—S100A12—Cytosolic sensors of pathogen-associated DNA—RELA—brain cancer	0.00142	0.00716	CbGpPWpGaD
Olopatadine—Urinary tract infection—Carmustine—brain cancer	0.0014	0.00676	CcSEcCtD
Olopatadine—Erythema—Hydroxyurea—brain cancer	0.0014	0.00672	CcSEcCtD
Olopatadine—Infestation—Temozolomide—brain cancer	0.0014	0.00672	CcSEcCtD
Olopatadine—Infestation NOS—Temozolomide—brain cancer	0.0014	0.00672	CcSEcCtD
Olopatadine—Depression—Temozolomide—brain cancer	0.00139	0.0067	CcSEcCtD
Olopatadine—S100B—Signaling by ERBB4—VAV1—brain cancer	0.00139	0.007	CbGpPWpGaD
Olopatadine—Nausea—Lomustine—brain cancer	0.00138	0.00663	CcSEcCtD
Olopatadine—Urinary tract infection—Temozolomide—brain cancer	0.00136	0.00653	CcSEcCtD
Olopatadine—S100B—Cytosolic sensors of pathogen-associated DNA—RELA—brain cancer	0.00134	0.00677	CbGpPWpGaD
Olopatadine—Sinusitis—Temozolomide—brain cancer	0.00131	0.0063	CcSEcCtD
Olopatadine—Somnolence—Procarbazine—brain cancer	0.00131	0.0063	CcSEcCtD
Olopatadine—Ill-defined disorder—Hydroxyurea—brain cancer	0.0013	0.00624	CcSEcCtD
Olopatadine—Hypoaesthesia—Carmustine—brain cancer	0.00129	0.00621	CcSEcCtD
Olopatadine—S100A12—TRAF6 Mediated Induction of proinflammatory cytokines—RELA—brain cancer	0.00128	0.00647	CbGpPWpGaD
Olopatadine—Fatigue—Procarbazine—brain cancer	0.00127	0.00611	CcSEcCtD
Olopatadine—S100A2—Direct p53 effectors—TP53—brain cancer	0.00127	0.0064	CbGpPWpGaD
Olopatadine—Malaise—Hydroxyurea—brain cancer	0.00126	0.00606	CcSEcCtD
Olopatadine—Pain—Procarbazine—brain cancer	0.00126	0.00606	CcSEcCtD
Olopatadine—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.00125	0.00633	CbGpPWpGaD
Olopatadine—Visual impairment—Carmustine—brain cancer	0.00125	0.00601	CcSEcCtD
Olopatadine—Hypoaesthesia—Temozolomide—brain cancer	0.00125	0.006	CcSEcCtD
Olopatadine—Pharyngitis—Temozolomide—brain cancer	0.00124	0.00599	CcSEcCtD
Olopatadine—S100A12—Cytosolic sensors of pathogen-associated DNA—CTNNB1—brain cancer	0.00123	0.00623	CbGpPWpGaD
Olopatadine—S100A12—RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways—RELA—brain cancer	0.00122	0.00614	CbGpPWpGaD
Olopatadine—Feeling abnormal—Procarbazine—brain cancer	0.00121	0.00584	CcSEcCtD
Olopatadine—Eye disorder—Carmustine—brain cancer	0.00121	0.00583	CcSEcCtD
Olopatadine—S100B—TRAF6 Mediated Induction of proinflammatory cytokines—RELA—brain cancer	0.00121	0.00611	CbGpPWpGaD
Olopatadine—Visual impairment—Temozolomide—brain cancer	0.00121	0.00581	CcSEcCtD
Olopatadine—Gastrointestinal pain—Procarbazine—brain cancer	0.0012	0.0058	CcSEcCtD
Olopatadine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.00119	0.00603	CbGpPWpGaD
Olopatadine—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—brain cancer	0.00118	0.00568	CcSEcCtD
Olopatadine—Discomfort—Hydroxyurea—brain cancer	0.00117	0.00565	CcSEcCtD
Olopatadine—Eye disorder—Temozolomide—brain cancer	0.00117	0.00564	CcSEcCtD
Olopatadine—S100B—Cytosolic sensors of pathogen-associated DNA—CTNNB1—brain cancer	0.00117	0.00589	CbGpPWpGaD
Olopatadine—Body temperature increased—Procarbazine—brain cancer	0.00116	0.0056	CcSEcCtD
Olopatadine—Abdominal pain—Procarbazine—brain cancer	0.00116	0.0056	CcSEcCtD
Olopatadine—S100A12—MyD88 cascade initiated on plasma membrane—RELA—brain cancer	0.00116	0.00585	CbGpPWpGaD
Olopatadine—S100B—RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways—RELA—brain cancer	0.00115	0.00581	CbGpPWpGaD
Olopatadine—S100A12—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—RELA—brain cancer	0.00115	0.0058	CbGpPWpGaD
Olopatadine—Oedema—Hydroxyurea—brain cancer	0.00114	0.00548	CcSEcCtD
Olopatadine—S100B—Signaling by ERBB4—PDGFRA—brain cancer	0.00114	0.00574	CbGpPWpGaD
Olopatadine—Infection—Hydroxyurea—brain cancer	0.00113	0.00545	CcSEcCtD
Olopatadine—Immune system disorder—Temozolomide—brain cancer	0.00113	0.00545	CcSEcCtD
Olopatadine—Mediastinal disorder—Temozolomide—brain cancer	0.00113	0.00544	CcSEcCtD
Olopatadine—Erythema—Carmustine—brain cancer	0.00113	0.00543	CcSEcCtD
Olopatadine—S100A12—MyD88 dependent cascade initiated on endosome—RELA—brain cancer	0.00113	0.00569	CbGpPWpGaD
Olopatadine—Nervous system disorder—Hydroxyurea—brain cancer	0.00112	0.00538	CcSEcCtD
Olopatadine—Infestation NOS—Etoposide—brain cancer	0.00112	0.00538	CcSEcCtD
Olopatadine—Infestation—Etoposide—brain cancer	0.00112	0.00538	CcSEcCtD
Olopatadine—Skin disorder—Hydroxyurea—brain cancer	0.00111	0.00533	CcSEcCtD
Olopatadine—Nortriptyline—CYP2C9—brain cancer	0.0011	0.386	CrCbGaD
Olopatadine—S100B—MyD88 cascade initiated on plasma membrane—RELA—brain cancer	0.00109	0.00553	CbGpPWpGaD
Olopatadine—Back pain—Carmustine—brain cancer	0.00109	0.00525	CcSEcCtD
Olopatadine—Erythema—Temozolomide—brain cancer	0.00109	0.00525	CcSEcCtD
Olopatadine—S100A12—Toll Like Receptor 9 (TLR9) Cascade—RELA—brain cancer	0.00109	0.00549	CbGpPWpGaD
Olopatadine—S100B—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—RELA—brain cancer	0.00108	0.00548	CbGpPWpGaD
Olopatadine—Hypersensitivity—Procarbazine—brain cancer	0.00108	0.00522	CcSEcCtD
Olopatadine—HRH1—endocrine gland—brain cancer	0.00108	0.00285	CbGeAlD
Olopatadine—S100A12—MyD88:Mal cascade initiated on plasma membrane—RELA—brain cancer	0.00107	0.0054	CbGpPWpGaD
Olopatadine—Dysgeusia—Temozolomide—brain cancer	0.00107	0.00514	CcSEcCtD
Olopatadine—S100B—MyD88 dependent cascade initiated on endosome—RELA—brain cancer	0.00107	0.00538	CbGpPWpGaD
Olopatadine—Vision blurred—Carmustine—brain cancer	0.00106	0.00512	CcSEcCtD
Olopatadine—HRH1—head—brain cancer	0.00106	0.00281	CbGeAlD
Olopatadine—Asthenia—Procarbazine—brain cancer	0.00106	0.00508	CcSEcCtD
Olopatadine—Back pain—Temozolomide—brain cancer	0.00105	0.00508	CcSEcCtD
Olopatadine—Pruritus—Procarbazine—brain cancer	0.00104	0.00501	CcSEcCtD
Olopatadine—S100B—Toll Like Receptor 9 (TLR9) Cascade—RELA—brain cancer	0.00103	0.00519	CbGpPWpGaD
Olopatadine—Vision blurred—Temozolomide—brain cancer	0.00103	0.00495	CcSEcCtD
Olopatadine—S100A12—MyD88-independent cascade—RELA—brain cancer	0.00102	0.00518	CbGpPWpGaD
Olopatadine—Dyspnoea—Hydroxyurea—brain cancer	0.00102	0.00489	CcSEcCtD
Olopatadine—Somnolence—Hydroxyurea—brain cancer	0.00101	0.00488	CcSEcCtD
Olopatadine—Ill-defined disorder—Temozolomide—brain cancer	0.00101	0.00487	CcSEcCtD
Olopatadine—S100B—MyD88:Mal cascade initiated on plasma membrane—RELA—brain cancer	0.00101	0.0051	CbGpPWpGaD
Olopatadine—Diarrhoea—Procarbazine—brain cancer	0.00101	0.00485	CcSEcCtD
Olopatadine—Hypoaesthesia—Etoposide—brain cancer	0.000997	0.0048	CcSEcCtD
Olopatadine—S100B—Signaling by ERBB4—IRS2—brain cancer	0.000997	0.00504	CbGpPWpGaD
Olopatadine—Doxepin—CYP2C9—brain cancer	0.000989	0.346	CrCbGaD
Olopatadine—Gastrointestinal disorder—Hydroxyurea—brain cancer	0.000984	0.00474	CcSEcCtD
Olopatadine—Malaise—Temozolomide—brain cancer	0.000983	0.00473	CcSEcCtD
Olopatadine—Fatigue—Hydroxyurea—brain cancer	0.000982	0.00473	CcSEcCtD
Olopatadine—Pain—Hydroxyurea—brain cancer	0.000974	0.00469	CcSEcCtD
Olopatadine—Dizziness—Procarbazine—brain cancer	0.000973	0.00469	CcSEcCtD
Olopatadine—HRH1—central nervous system—brain cancer	0.00097	0.00257	CbGeAlD
Olopatadine—S100B—MyD88-independent cascade—RELA—brain cancer	0.000969	0.0049	CbGpPWpGaD
Olopatadine—Cough—Temozolomide—brain cancer	0.000952	0.00458	CcSEcCtD
Olopatadine—Feeling abnormal—Hydroxyurea—brain cancer	0.000939	0.00452	CcSEcCtD
Olopatadine—Eye disorder—Etoposide—brain cancer	0.000937	0.00451	CcSEcCtD
Olopatadine—Vomiting—Procarbazine—brain cancer	0.000936	0.00451	CcSEcCtD
Olopatadine—Rash—Procarbazine—brain cancer	0.000928	0.00447	CcSEcCtD
Olopatadine—Dermatitis—Procarbazine—brain cancer	0.000927	0.00446	CcSEcCtD
Olopatadine—Headache—Procarbazine—brain cancer	0.000922	0.00444	CcSEcCtD
Olopatadine—S100A12—Activated TLR4 signalling—RELA—brain cancer	0.000922	0.00466	CbGpPWpGaD
Olopatadine—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—brain cancer	0.000922	0.00444	CcSEcCtD
Olopatadine—Oedema—Carmustine—brain cancer	0.000921	0.00443	CcSEcCtD
Olopatadine—Discomfort—Temozolomide—brain cancer	0.000917	0.00442	CcSEcCtD
Olopatadine—Infection—Carmustine—brain cancer	0.000915	0.0044	CcSEcCtD
Olopatadine—Dry mouth—Temozolomide—brain cancer	0.000908	0.00437	CcSEcCtD
Olopatadine—Immune system disorder—Etoposide—brain cancer	0.000905	0.00436	CcSEcCtD
Olopatadine—Mediastinal disorder—Etoposide—brain cancer	0.000903	0.00435	CcSEcCtD
Olopatadine—Body temperature increased—Hydroxyurea—brain cancer	0.000901	0.00434	CcSEcCtD
Olopatadine—Oedema—Temozolomide—brain cancer	0.00089	0.00428	CcSEcCtD
Olopatadine—Infection—Temozolomide—brain cancer	0.000884	0.00426	CcSEcCtD
Olopatadine—Nausea—Procarbazine—brain cancer	0.000874	0.00421	CcSEcCtD
Olopatadine—Nervous system disorder—Temozolomide—brain cancer	0.000873	0.0042	CcSEcCtD
Olopatadine—S100B—Activated TLR4 signalling—RELA—brain cancer	0.000872	0.00441	CbGpPWpGaD
Olopatadine—S100A12—Toll Like Receptor 4 (TLR4) Cascade—RELA—brain cancer	0.000867	0.00438	CbGpPWpGaD
Olopatadine—Skin disorder—Temozolomide—brain cancer	0.000865	0.00416	CcSEcCtD
Olopatadine—Dysgeusia—Etoposide—brain cancer	0.000855	0.00411	CcSEcCtD
Olopatadine—Back pain—Etoposide—brain cancer	0.000844	0.00406	CcSEcCtD
Olopatadine—Hypersensitivity—Hydroxyurea—brain cancer	0.000839	0.00404	CcSEcCtD
Olopatadine—Muscle spasms—Etoposide—brain cancer	0.000839	0.00404	CcSEcCtD
Olopatadine—CYP3A4—endocrine gland—brain cancer	0.000832	0.0022	CbGeAlD
Olopatadine—Dyspnoea—Carmustine—brain cancer	0.000821	0.00395	CcSEcCtD
Olopatadine—S100B—Toll Like Receptor 4 (TLR4) Cascade—RELA—brain cancer	0.00082	0.00414	CbGpPWpGaD
Olopatadine—Somnolence—Carmustine—brain cancer	0.000819	0.00394	CcSEcCtD
Olopatadine—Asthenia—Hydroxyurea—brain cancer	0.000817	0.00394	CcSEcCtD
Olopatadine—Ill-defined disorder—Etoposide—brain cancer	0.00081	0.0039	CcSEcCtD
Olopatadine—Gastrointestinal disorder—Carmustine—brain cancer	0.000795	0.00383	CcSEcCtD
Olopatadine—Dyspnoea—Temozolomide—brain cancer	0.000793	0.00382	CcSEcCtD
Olopatadine—Somnolence—Temozolomide—brain cancer	0.000791	0.00381	CcSEcCtD
Olopatadine—Pain—Carmustine—brain cancer	0.000788	0.00379	CcSEcCtD
Olopatadine—Malaise—Etoposide—brain cancer	0.000787	0.00379	CcSEcCtD
Olopatadine—Diarrhoea—Hydroxyurea—brain cancer	0.00078	0.00375	CcSEcCtD
Olopatadine—S100A12—Toll-Like Receptors Cascades—RELA—brain cancer	0.000772	0.0039	CbGpPWpGaD
Olopatadine—HRH1—brain—brain cancer	0.00077	0.00204	CbGeAlD
Olopatadine—Gastrointestinal disorder—Temozolomide—brain cancer	0.000768	0.0037	CcSEcCtD
Olopatadine—Fatigue—Temozolomide—brain cancer	0.000767	0.00369	CcSEcCtD
Olopatadine—Amitriptyline—CYP2C9—brain cancer	0.000765	0.268	CrCbGaD
Olopatadine—Cough—Etoposide—brain cancer	0.000761	0.00367	CcSEcCtD
Olopatadine—Pain—Temozolomide—brain cancer	0.000761	0.00366	CcSEcCtD
Olopatadine—Feeling abnormal—Carmustine—brain cancer	0.000759	0.00365	CcSEcCtD
Olopatadine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000758	0.00383	CbGpPWpGaD
Olopatadine—Dizziness—Hydroxyurea—brain cancer	0.000753	0.00363	CcSEcCtD
Olopatadine—Gastrointestinal pain—Carmustine—brain cancer	0.000753	0.00363	CcSEcCtD
Olopatadine—CYP3A4—central nervous system—brain cancer	0.00075	0.00198	CbGeAlD
Olopatadine—S100B—Signaling Pathways—OR4C12—brain cancer	0.000749	0.00378	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—OR14C36—brain cancer	0.000749	0.00378	CbGpPWpGaD
Olopatadine—CYP3A4—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000748	0.00378	CbGpPWpGaD
Olopatadine—Unspecified disorder of skin and subcutaneous tissue—Etoposide—brain cancer	0.000738	0.00355	CcSEcCtD
Olopatadine—Discomfort—Etoposide—brain cancer	0.000734	0.00353	CcSEcCtD
Olopatadine—Feeling abnormal—Temozolomide—brain cancer	0.000733	0.00353	CcSEcCtD
Olopatadine—S100B—Toll-Like Receptors Cascades—RELA—brain cancer	0.00073	0.00369	CbGpPWpGaD
Olopatadine—Body temperature increased—Carmustine—brain cancer	0.000728	0.00351	CcSEcCtD
Olopatadine—Abdominal pain—Carmustine—brain cancer	0.000728	0.00351	CcSEcCtD
Olopatadine—Gastrointestinal pain—Temozolomide—brain cancer	0.000728	0.0035	CcSEcCtD
Olopatadine—Vomiting—Hydroxyurea—brain cancer	0.000724	0.00349	CcSEcCtD
Olopatadine—Rash—Hydroxyurea—brain cancer	0.000718	0.00346	CcSEcCtD
Olopatadine—Dermatitis—Hydroxyurea—brain cancer	0.000718	0.00346	CcSEcCtD
Olopatadine—Headache—Hydroxyurea—brain cancer	0.000714	0.00344	CcSEcCtD
Olopatadine—Infection—Etoposide—brain cancer	0.000708	0.00341	CcSEcCtD
Olopatadine—Abdominal pain—Temozolomide—brain cancer	0.000704	0.00339	CcSEcCtD
Olopatadine—Body temperature increased—Temozolomide—brain cancer	0.000704	0.00339	CcSEcCtD
Olopatadine—Skin disorder—Etoposide—brain cancer	0.000692	0.00333	CcSEcCtD
Olopatadine—S100B—Signaling by ERBB4—ERBB2—brain cancer	0.000683	0.00345	CbGpPWpGaD
Olopatadine—Hypersensitivity—Carmustine—brain cancer	0.000679	0.00327	CcSEcCtD
Olopatadine—Nausea—Hydroxyurea—brain cancer	0.000677	0.00326	CcSEcCtD
Olopatadine—Asthenia—Carmustine—brain cancer	0.000661	0.00318	CcSEcCtD
Olopatadine—Hypersensitivity—Temozolomide—brain cancer	0.000656	0.00316	CcSEcCtD
Olopatadine—CYP3A4—Irinotecan Pathway—APC—brain cancer	0.000643	0.00325	CbGpPWpGaD
Olopatadine—Asthenia—Temozolomide—brain cancer	0.000639	0.00307	CcSEcCtD
Olopatadine—HRH1—IL-4 Signaling Pathway—IRS2—brain cancer	0.000637	0.00322	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—DTX2—brain cancer	0.000637	0.00322	CbGpPWpGaD
Olopatadine—Dyspnoea—Etoposide—brain cancer	0.000635	0.00306	CcSEcCtD
Olopatadine—Somnolence—Etoposide—brain cancer	0.000633	0.00305	CcSEcCtD
Olopatadine—Diarrhoea—Carmustine—brain cancer	0.00063	0.00303	CcSEcCtD
Olopatadine—Pruritus—Temozolomide—brain cancer	0.00063	0.00303	CcSEcCtD
Olopatadine—Gastrointestinal disorder—Etoposide—brain cancer	0.000615	0.00296	CcSEcCtD
Olopatadine—CYP3A4—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000614	0.0031	CbGpPWpGaD
Olopatadine—Fatigue—Etoposide—brain cancer	0.000614	0.00296	CcSEcCtD
Olopatadine—Dizziness—Carmustine—brain cancer	0.000609	0.00293	CcSEcCtD
Olopatadine—Pain—Etoposide—brain cancer	0.000609	0.00293	CcSEcCtD
Olopatadine—Diarrhoea—Temozolomide—brain cancer	0.000609	0.00293	CcSEcCtD
Olopatadine—Dizziness—Temozolomide—brain cancer	0.000589	0.00283	CcSEcCtD
Olopatadine—Feeling abnormal—Etoposide—brain cancer	0.000587	0.00283	CcSEcCtD
Olopatadine—Vomiting—Carmustine—brain cancer	0.000586	0.00282	CcSEcCtD
Olopatadine—Gastrointestinal pain—Etoposide—brain cancer	0.000582	0.0028	CcSEcCtD
Olopatadine—Rash—Carmustine—brain cancer	0.000581	0.0028	CcSEcCtD
Olopatadine—Dermatitis—Carmustine—brain cancer	0.00058	0.00279	CcSEcCtD
Olopatadine—Headache—Carmustine—brain cancer	0.000577	0.00278	CcSEcCtD
Olopatadine—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—brain cancer	0.000571	0.00288	CbGpPWpGaD
Olopatadine—Vomiting—Temozolomide—brain cancer	0.000566	0.00272	CcSEcCtD
Olopatadine—Abdominal pain—Etoposide—brain cancer	0.000563	0.00271	CcSEcCtD
Olopatadine—Body temperature increased—Etoposide—brain cancer	0.000563	0.00271	CcSEcCtD
Olopatadine—Rash—Temozolomide—brain cancer	0.000561	0.0027	CcSEcCtD
Olopatadine—Dermatitis—Temozolomide—brain cancer	0.000561	0.0027	CcSEcCtD
Olopatadine—Headache—Temozolomide—brain cancer	0.000558	0.00268	CcSEcCtD
Olopatadine—Nausea—Carmustine—brain cancer	0.000547	0.00263	CcSEcCtD
Olopatadine—Nausea—Temozolomide—brain cancer	0.000529	0.00255	CcSEcCtD
Olopatadine—Hypersensitivity—Etoposide—brain cancer	0.000525	0.00253	CcSEcCtD
Olopatadine—Asthenia—Etoposide—brain cancer	0.000511	0.00246	CcSEcCtD
Olopatadine—S100A12—Innate Immune System—VAV1—brain cancer	0.000504	0.00255	CbGpPWpGaD
Olopatadine—Pruritus—Etoposide—brain cancer	0.000504	0.00243	CcSEcCtD
Olopatadine—Diarrhoea—Etoposide—brain cancer	0.000487	0.00235	CcSEcCtD
Olopatadine—S100B—Signaling Pathways—PTCH2—brain cancer	0.000482	0.00244	CbGpPWpGaD
Olopatadine—S100B—Innate Immune System—VAV1—brain cancer	0.000477	0.00241	CbGpPWpGaD
Olopatadine—S100B—Signaling by ERBB4—EGFR—brain cancer	0.000474	0.00239	CbGpPWpGaD
Olopatadine—Dizziness—Etoposide—brain cancer	0.000471	0.00227	CcSEcCtD
Olopatadine—S100B—Signaling Pathways—HES5—brain cancer	0.000467	0.00236	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—STRADA—brain cancer	0.000454	0.00229	CbGpPWpGaD
Olopatadine—Vomiting—Etoposide—brain cancer	0.000453	0.00218	CcSEcCtD
Olopatadine—Rash—Etoposide—brain cancer	0.000449	0.00216	CcSEcCtD
Olopatadine—Dermatitis—Etoposide—brain cancer	0.000449	0.00216	CcSEcCtD
Olopatadine—Headache—Etoposide—brain cancer	0.000446	0.00215	CcSEcCtD
Olopatadine—HRH1—GPCR ligand binding—PTCH2—brain cancer	0.000444	0.00225	CbGpPWpGaD
Olopatadine—HRH1—IL-4 Signaling Pathway—RELA—brain cancer	0.00044	0.00222	CbGpPWpGaD
Olopatadine—HRH1—G alpha (q) signalling events—TRPC6—brain cancer	0.000438	0.00221	CbGpPWpGaD
Olopatadine—Nausea—Etoposide—brain cancer	0.000423	0.00204	CcSEcCtD
Olopatadine—S100A12—Innate Immune System—PDGFRA—brain cancer	0.000413	0.00209	CbGpPWpGaD
Olopatadine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—TRPC6—brain cancer	0.000392	0.00198	CbGpPWpGaD
Olopatadine—S100B—Innate Immune System—PDGFRA—brain cancer	0.000391	0.00197	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—OR4C12—brain cancer	0.00039	0.00197	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—OR14C36—brain cancer	0.00039	0.00197	CbGpPWpGaD
Olopatadine—S100A12—Immune System—SKP2—brain cancer	0.000385	0.00195	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—ABR—brain cancer	0.000379	0.00191	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—GLI2—brain cancer	0.000366	0.00185	CbGpPWpGaD
Olopatadine—S100B—Immune System—SKP2—brain cancer	0.000364	0.00184	CbGpPWpGaD
Olopatadine—S100A12—Innate Immune System—IRS2—brain cancer	0.000363	0.00183	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—OR4C12—brain cancer	0.000354	0.00179	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—OR14C36—brain cancer	0.000354	0.00179	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—GLI1—brain cancer	0.000344	0.00174	CbGpPWpGaD
Olopatadine—S100B—Innate Immune System—IRS2—brain cancer	0.000343	0.00173	CbGpPWpGaD
Olopatadine—HRH1—IL-4 Signaling Pathway—STAT3—brain cancer	0.000333	0.00168	CbGpPWpGaD
Olopatadine—CYP3A4—Biological oxidations—CYP2C9—brain cancer	0.000326	0.00165	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—SUFU—brain cancer	0.000326	0.00165	CbGpPWpGaD
Olopatadine—CYP3A4—Metapathway biotransformation—CYP2C9—brain cancer	0.000322	0.00163	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—GFAP—brain cancer	0.000314	0.00159	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—HEY1—brain cancer	0.000298	0.00151	CbGpPWpGaD
Olopatadine—S100A12—Immune System—VAV1—brain cancer	0.000294	0.00148	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—DLL1—brain cancer	0.000292	0.00148	CbGpPWpGaD
Olopatadine—S100B—Immune System—VAV1—brain cancer	0.000278	0.0014	CbGpPWpGaD
Olopatadine—S100A12—Innate Immune System—RELA—brain cancer	0.00025	0.00126	CbGpPWpGaD
Olopatadine—S100A12—Innate Immune System—ERBB2—brain cancer	0.000249	0.00126	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—SHH—brain cancer	0.000249	0.00126	CbGpPWpGaD
Olopatadine—S100A12—Immune System—PDGFRA—brain cancer	0.000241	0.00122	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—TRPC6—brain cancer	0.00024	0.00121	CbGpPWpGaD
Olopatadine—S100B—Innate Immune System—RELA—brain cancer	0.000237	0.0012	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—PTCH1—brain cancer	0.000236	0.00119	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—SMO—brain cancer	0.000236	0.00119	CbGpPWpGaD
Olopatadine—S100B—Innate Immune System—ERBB2—brain cancer	0.000235	0.00119	CbGpPWpGaD
Olopatadine—HRH1—GPCR ligand binding—SHH—brain cancer	0.000229	0.00116	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—PTCH2—brain cancer	0.000228	0.00115	CbGpPWpGaD
Olopatadine—S100B—Immune System—PDGFRA—brain cancer	0.000227	0.00115	CbGpPWpGaD
Olopatadine—S100A12—Innate Immune System—CTNNB1—brain cancer	0.000218	0.0011	CbGpPWpGaD
Olopatadine—HRH1—GPCR ligand binding—SMO—brain cancer	0.000217	0.0011	CbGpPWpGaD
Olopatadine—HRH1—GPCR ligand binding—PTCH1—brain cancer	0.000217	0.0011	CbGpPWpGaD
Olopatadine—S100A12—Immune System—IRS2—brain cancer	0.000211	0.00107	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—OR14C36—brain cancer	0.000209	0.00106	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—OR4C12—brain cancer	0.000209	0.00106	CbGpPWpGaD
Olopatadine—S100B—Innate Immune System—CTNNB1—brain cancer	0.000206	0.00104	CbGpPWpGaD
Olopatadine—S100B—Immune System—IRS2—brain cancer	0.0002	0.00101	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—ABR—brain cancer	0.000197	0.000996	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—NOTCH2—brain cancer	0.000188	0.000952	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—VAV1—brain cancer	0.00018	0.000907	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—ABR—brain cancer	0.000179	0.000904	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—DTX2—brain cancer	0.000178	0.000898	CbGpPWpGaD
Olopatadine—S100A12—Innate Immune System—EGFR—brain cancer	0.000172	0.000871	CbGpPWpGaD
Olopatadine—S100B—Innate Immune System—EGFR—brain cancer	0.000163	0.000823	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—HES1—brain cancer	0.000154	0.00078	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—PDGFRA—brain cancer	0.000147	0.000743	CbGpPWpGaD
Olopatadine—S100A12—Immune System—RELA—brain cancer	0.000146	0.000736	CbGpPWpGaD
Olopatadine—S100A12—Immune System—ERBB2—brain cancer	0.000145	0.000732	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—SPP1—brain cancer	0.000143	0.000721	CbGpPWpGaD
Olopatadine—S100B—Immune System—RELA—brain cancer	0.000138	0.000696	CbGpPWpGaD
Olopatadine—S100B—Immune System—ERBB2—brain cancer	0.000137	0.000692	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—PTCH2—brain cancer	0.000135	0.000681	CbGpPWpGaD
Olopatadine—S100A12—Immune System—IL2—brain cancer	0.000131	0.000663	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—HES5—brain cancer	0.000131	0.000659	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—IRS2—brain cancer	0.000129	0.000652	CbGpPWpGaD
Olopatadine—S100A12—Immune System—CTNNB1—brain cancer	0.000127	0.00064	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—STRADA—brain cancer	0.000127	0.00064	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—TRPC6—brain cancer	0.000125	0.00063	CbGpPWpGaD
Olopatadine—S100B—Immune System—IL2—brain cancer	0.000124	0.000627	CbGpPWpGaD
Olopatadine—S100B—Immune System—CTNNB1—brain cancer	0.00012	0.000605	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—SHH—brain cancer	0.000118	0.000594	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—APC—brain cancer	0.000114	0.000576	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—PIK3CG—brain cancer	0.000114	0.000576	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—TRPC6—brain cancer	0.000113	0.000572	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—PTCH1—brain cancer	0.000111	0.000563	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—SMO—brain cancer	0.000111	0.000563	CbGpPWpGaD
Olopatadine—S100A12—Immune System—STAT3—brain cancer	0.00011	0.000558	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—ABR—brain cancer	0.000106	0.000534	CbGpPWpGaD
Olopatadine—S100B—Immune System—STAT3—brain cancer	0.000104	0.000528	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—GLI2—brain cancer	0.000102	0.000516	CbGpPWpGaD
Olopatadine—S100A12—Immune System—EGFR—brain cancer	0.0001	0.000507	CbGpPWpGaD
Olopatadine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—brain cancer	0.0001	0.000507	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—GLI1—brain cancer	9.6e-05	0.000485	CbGpPWpGaD
Olopatadine—S100B—Immune System—EGFR—brain cancer	9.49e-05	0.00048	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—VAV1—brain cancer	9.35e-05	0.000472	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—SUFU—brain cancer	9.1e-05	0.00046	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—RELA—brain cancer	8.91e-05	0.00045	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—ERBB2—brain cancer	8.85e-05	0.000447	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—GFAP—brain cancer	8.78e-05	0.000444	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—VAV1—brain cancer	8.49e-05	0.000429	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—HEY1—brain cancer	8.32e-05	0.000421	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—DLL1—brain cancer	8.16e-05	0.000412	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—IL2—brain cancer	8.02e-05	0.000405	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—CCND1—brain cancer	7.82e-05	0.000395	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—CTNNB1—brain cancer	7.75e-05	0.000391	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—SHH—brain cancer	6.94e-05	0.000351	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—VEGFA—brain cancer	6.82e-05	0.000345	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—STAT3—brain cancer	6.75e-05	0.000341	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—TRPC6—brain cancer	6.69e-05	0.000338	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—PTCH1—brain cancer	6.58e-05	0.000332	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—SMO—brain cancer	6.58e-05	0.000332	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—MYC—brain cancer	6.27e-05	0.000317	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—EGFR—brain cancer	6.14e-05	0.00031	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—PIK3CG—brain cancer	5.94e-05	0.0003	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—CYP2C9—brain cancer	5.58e-05	0.000282	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—PIK3CG—brain cancer	5.39e-05	0.000272	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—NOTCH2—brain cancer	5.26e-05	0.000266	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—TP53—brain cancer	5.15e-05	0.00026	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—VAV1—brain cancer	5.02e-05	0.000253	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—BSG—brain cancer	4.74e-05	0.00024	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—HES1—brain cancer	4.31e-05	0.000218	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—IL2—brain cancer	4.18e-05	0.000211	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—PDGFRA—brain cancer	4.11e-05	0.000207	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—IDH1—brain cancer	4.08e-05	0.000206	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—SPP1—brain cancer	3.99e-05	0.000201	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—IL2—brain cancer	3.79e-05	0.000192	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—IRS2—brain cancer	3.61e-05	0.000182	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—ENO2—brain cancer	3.22e-05	0.000163	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—PIK3CG—brain cancer	3.18e-05	0.000161	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—APC—brain cancer	3.18e-05	0.000161	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—EGFR—brain cancer	2.9e-05	0.000147	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—RELA—brain cancer	2.49e-05	0.000126	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—ERBB2—brain cancer	2.47e-05	0.000125	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—IL2—brain cancer	2.24e-05	0.000113	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—CCND1—brain cancer	2.18e-05	0.00011	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—CTNNB1—brain cancer	2.16e-05	0.000109	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—VEGFA—brain cancer	1.9e-05	9.62e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—STAT3—brain cancer	1.89e-05	9.53e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—MYC—brain cancer	1.75e-05	8.85e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—EGFR—brain cancer	1.71e-05	8.66e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—PIK3CG—brain cancer	1.48e-05	7.47e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—TP53—brain cancer	1.44e-05	7.27e-05	CbGpPWpGaD
